Medical Facilities Corporation (TSX:DR)
Canada · Delayed Price · Currency is CAD | Market Cap | 294.49M +4.0% |
| Revenue (ttm) | 363.93M +16.0% |
| Net Income | 58.99M -44.0% |
| EPS | 2.94 -34.9% |
| Shares Out | 17.55M |
| PE Ratio | 13.74 |
| Forward PE | 8.81 |
| Dividend | 0.36 (2.15%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 43,196 |
| Average Volume | 24,686 |
| Open | 16.78 |
| Previous Close | 16.78 |
| Day's Range | 16.70 - 17.18 |
| 52-Week Range | 13.59 - 18.17 |
| Beta | 0.36 |
| RSI | 46.01 |
| Earnings Date | May 7, 2026 |
About Medical Facilities
Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals in the United States. Its specialty surgical hospitals offer non-emergency surgical, imaging, diagnostic and pain management procedures, and other ancillary services, such as primary and urgent care. The company is also involved in the facility fee charged to the patient, or insurer for the use of its infrastructure, surgical equipment, nursing staff, non-surgical professional services, drugs and supplies, and other support services. Medical... [Read more]
Financial Performance
In 2025, Medical Facilities's revenue was $254.17 million, an increase of 3.28% compared to the previous year's $246.09 million. Earnings were $21.26 million, a decrease of -71.08%.
Financial numbers in USD Financial StatementsNews
Medical Facilities price target raised to C$19 from C$17 at RBC Capital
RBC Capital raised the firm’s price target on Medical Facilities (MFCSF) to C$19 from C$17 and keeps a Sector Perform rating on the shares.
Medical Facilities Earnings Call Transcript: Q1 2026
Facility service revenue grew 10.8% year-over-year to $67.1 million, with income from operations up 17.6% and EBITDA up 13.8%. Sale of Oklahoma Spine Hospital boosted cash to $86.3 million, supporting ongoing capital returns and strategic focus.
Medical Facilities Earnings Call Transcript: Q4 2025
Q4 and full-year results showed strong revenue and earnings growth, supported by higher case volumes and operational efficiency. Major asset sales and share repurchases returned significant capital to shareholders, while the company remains debt-free and continues to monitor regulatory and competitive risks.
Medical Facilities Earnings Call Transcript: Q3 2025
Income from operations and EBITDA grew strongly, driven by higher facility service revenue and improved case mix. Share repurchases reduced the outstanding share count by 20% year-to-date, while the company maintained a strong cash position and no corporate debt.
Medical Facilities Earnings Call Transcript: Q2 2025
Second quarter results were impacted by lower volumes at Sioux Falls due to a clinic relocation, but other hospitals saw improved profitability. $52.2 million was returned to shareholders, and a new $40 million credit facility was secured. Operations at Sioux Falls are expected to normalize in the second half.
Medical Facilities Earnings Call Transcript: Q1 2025
First quarter revenue and EBITDA were stable year-over-year, with higher surgical volumes offsetting one less surgical day. Significant capital was returned to shareholders, and the company maintains a strong cash position with no corporate debt.
Medical Facilities Earnings Call Transcript: Q4 2024
Strong 2024 results included higher income from operations and adjusted EBITDA, driven by the sale of a major asset and robust capital returns to shareholders. Q4 saw a slight revenue dip due to lower surgical volumes, but liquidity and balance sheet strength improved significantly.
Medical Facilities price target raised to C$17 from C$16 at RBC Capital
RBC Capital analyst Douglas Miehm raised the firm’s price target on Medical Facilities (MFCSF) to C$17 from C$16 and keeps a Sector Perform rating on the shares. Published first on
Medical Facilities price target raised to C$16 from C$14 at RBC Capital
RBC Capital raised the firm’s price target on Medical Facilities (MFCSF) to C$16 from C$14 and keeps a Sector Perform rating on the shares.
Medical Facilities Earnings Call Transcript: Q3 2024
Q3 revenue rose 11.2% to $115M, driven by $11.4M in PPP loan forgiveness, while operating income and EBITDA grew 11.7% and 8.3% year-over-year. Capital returns to shareholders and debt reduction continued.
Medical Facilities price target raised to C$14 from C$13 at RBC Capital
RBC Capital analyst Douglas Miehm raised the firm’s price target on Medical Facilities to C$14 from C$13 and keeps a Sector Perform rating on the shares.
Medical Facilities Earnings Call Transcript: Q2 2024
Hospitals achieved higher surgical and pain management volumes, boosting revenue and EBITDA year-over-year. Black Hills expanded into heart and vascular care, while $6.9 million in PPP loans were forgiven post-quarter. Capital was returned to shareholders and debt reduced.
Medical Facilities price target raised to C$13 from C$12 at RBC Capital
RBC Capital raised the firm’s price target on Medical Facilities to C$13 from C$12 and keeps a Sector Perform rating on the shares.
Medical Facilities Earnings Call Transcript: Q1 2024
Medical Facilities price target raised to C$12 from C$11 at RBC Capital
RBC Capital analyst Douglas Miehm raised the firm’s price target on Medical Facilities to C$12 from C$11 and keeps a Sector Perform rating on the shares.
Medical Facilities Earnings Call Transcript: Q4 2023
Medical Facilities Earnings Call Transcript: Q3 2023
Medical Facilities price target raised to C$11 from C$10 at RBC Capital
RBC Capital analyst Douglas Miehm raised the firm’s price target on Medical Facilities to C$11 from C$10 and keeps a Sector Perform rating on the shares.
Medical Facilities Earnings Call Transcript: Q2 2023
Medical Facilities Earnings Call Transcript: Q1 2023
Medical Facilities Earnings Call Transcript: Q4 2022
Medical Facilities price target lowered to C$10 from C$11 at National Bank
National Bank analyst Endri Leno lowered the firm’s price target on Medical Facilities to C$10 from C$11 and keeps a Sector Perform rating on the shares.
Medical Facilities price target lowered to C$10 from C$11 at RBC Capital
RBC Capital analyst Douglas Miehm lowered the firm’s price target on Medical Facilities to C$10 from C$11 and keeps a Sector Perform rating on the shares.